Treatment with Fluvastatin Rapidly Modulates, via Different Pathways, and in Dependence on the Baseline Level, Inflammation in Hemodialysis Patients

Publisher： Karger

E-ISSN： 1421-9735|22|6|518-524

ISSN： 0253-5068

Source： Blood Purification, Vol.22, Iss.6, 2005-01, pp. : 518-524

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Exploring Inflammation in Hemodialysis Patients: Persistent and Superimposed Inflammation

By  

Kidney and Blood Pressure Research, Vol. 27, Iss. 2, 2004-05 ,pp. : 63-70

Karger

Access to resources Recommend Favorite

Renal Anemia Treatment with ESA in Hemodialysis Patients in Relation to Early versus Late Referral in Everyday Clinical Practice in Central and Eastern European Countries: Baseline Data

By  

Kidney and Blood Pressure Research, Vol. 35, Iss. 1, 2011-08 ,pp. : 58-67

Karger

Access to resources Recommend Favorite

Periodontitis Is an Important and Occult Source of Inflammation in Hemodialysis Patients

By  

Blood Purification, Vol. 24, Iss. 4, 2006-08 ,pp. : 400-404

Karger

Access to resources Recommend Favorite

Triad of Malnutrition, Inflammation, and Atherosclerosis in Hemodialysis Patients

By  

Nephron, Vol. 91, Iss. 3, 2002-07 ,pp. : 456-462

Karger

Access to resources Recommend Favorite

Efficiency of 1-Year Treatment with Fluvastatin in Hyperlipidemic Patients with Nephrotic Syndrome

By  

American Journal of Nephrology, Vol. 19, Iss. 4, 1999-08 ,pp. : 492-494

Karger

Access to resources Recommend Favorite